Study In Asthma Control

NCT00273026 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2018-03-21

No results posted yet for this study

Summary

This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.

Conditions

Interventions

DRUG

salmeterol xinafoate/fluticasone propionate

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-08
Completion
2006-03-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273026 on ClinicalTrials.gov